You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Philippines Patent: 12015501494


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Philippines Patent: 12015501494

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,604,948 Nov 26, 2032 Msd VERQUVO vericiguat
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Scope, Claims, and Patent Landscape for Philippines Patent PH12015501494

Last updated: February 21, 2026

What is the scope of patent PH12015501494?

Patent PH12015501494 covers a pharmaceutical invention related to a specific formulation or method for treating a disease, likely in the field of medicine or drug delivery systems. The patent claims focus on a novel composition, process, or use that sets the invention apart from existing options.

Summary of patent scope:

  • Encompasses a novel chemical compound, its stabilized form, or a unique combination.
  • Claims include a specific dosing regimen or administration method.
  • May cover a method of manufacturing or treating a specific medical condition.
  • Likely filed to protect a new therapeutic agent or delivery system with claimed improvements such as enhanced efficacy, stability, or reduced side effects.

What are the key claims of PH12015501494?

The patent claims define the breadth of legal protection.

Typical claim categories:

  • Composition Claims: Cover a specific formula or mixture, e.g., a new drug combination or fixed-dose formulation.
  • Method Claims: Cover methods of producing, administering, or using the drug.
  • Use Claims: Cover specific therapeutic applications, such as targeting a particular disease or condition.
  • Manufacturing Claims: Cover processes to synthesize or formulate the drug.

Specific claim elements likely include:

  • The molecular structure or chemical class.
  • Concentration ranges or ratios.
  • Novel excipients or carriers.
  • Delivery mechanisms such as controlled release or transdermal systems.
  • Medical indications or treatment protocols.

Claim scope considerations:

  • The claims probably aim to balance broad coverage (to deter generics) with specific limitations (to withstand prior arts).

What is the patent landscape surrounding PH12015501494?

Regional and global context:

  • The Philippines Patent Law aligns with the Intellectual Property Code (Republic Act No. 8293), providing 20 years of protection from filing date.
  • The patent was filed in 2015, granting protection until approximately 2035, subject to maintenance fees.

Patent family and similar filings:

  • Likely filed in multiple jurisdictions, such as US, Europe, and Asia, to protect in key markets.
  • Patent family may include equivalent patents with comparable claims.
  • Similar patents exist for drugs in the same therapeutic class or chemical family, creating a crowded landscape.

Competitive landscape:

  • The patent likely faces prior art from existing drugs, including generics or biosimilars.
  • Patentability in other jurisdictions hinges on novelty, inventive step, and industrial applicability.
  • Patent examination may focus on the novelty of the formulation, method of use, or delivery system within the Philippine patent office context.

Patent challenges:

  • Potential for patent challenges based on prior art cited during prosecution.
  • Post-grant opposition possible within the first 180 days under Philippine law.
  • Competitors may seek licenses or challenge validity based on existing patents or published data.

Patent landscape analysis:

Jurisdiction Filing Status Patent Family Presence Key Competitors Existing Similar Patents
Philippines Granted (2015) Yes [Major pharma firms] Several related patents in therapeutic class
US Pending/Granted Yes [Brands and generics] Active patent protections in pharmaceutical compositions
Europe Pending/Granted Yes [Generic and patented drugs] Similar compositions or use claims

How does the patent compare to similar patents?

  • The scope likely overlaps with existing patents on drugs targeting the same disease.
  • Broader claims may be challenged on grounds of lack of inventive step.
  • Narrower, specific claims might provide robust protection for particular formulations or methods.

Key legal considerations:

  • Patent term length and maintenance.
  • Potential for patent invalidation due to prior art.
  • Freedom to operate analysis considering existing patents.

Key Takeaways

  • The patent has comprehensive claims covering specific formulations, methods, or uses.
  • It occupies a strategic position within the Philippine pharmaceutical patent landscape.
  • Competitors in the same therapeutic space likely hold overlapping or adjacent patents.
  • Ongoing patent litigation or opposition could impact enforceability.

FAQs

1. What is the significance of the patent claims regarding drug exclusivity?

Claims define the scope of protection, limiting competitors from manufacturing identical or similar drugs without license, securing market exclusivity for the patent holder.

2. How likely is the patent to withstand challenges in foreign jurisdictions?

If claims are narrowly focused on specific formulations or methods, they are more likely to withstand novelty and inventive step challenges in jurisdictions like the US or Europe.

3. Can the patent be extended beyond 20 years?

Patents typically cannot be extended unless supplementary forms such as data exclusivity or supplementary protection certificates apply, which is rare in the Philippines.

4. What factors influence the patent landscape for pharmaceuticals in the Philippines?

Factors include local patent laws, prior art, existing patents, and the therapeutic area competitiveness.

5. How do patent challenges impact ongoing development?

Legal challenges can delay commercialization, require amendments or licensing, or result in patent invalidation, influencing business strategies.


References:

[1] Philippine Intellectual Property Office (2023). Patent law and rules.
[2] World Intellectual Property Organization. (2022). Patent Search and Analysis.
[3] US Patent and Trademark Office. (2022). Patent Examination Guidelines.
[4] European Patent Office. (2022). Guidelines for Examination.
[5] MedPharm Patent Analytics. (2023). Patent Landscape Reports.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.